Monday, August 31, 2026 SourcesAbout🌓
🇺🇸 US ▾
BREAKING
Business

This cancer drug stock could double as its treatment hits the market, JPMorgan says

CNBC ·

The investment bank initiated coverage with an overweight rating.

Read the full article on CNBC ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cnbc.com — the content belongs to CNBC.

More from CNBC

See all ›

More in Business

See all ›